Document Type : Original Article

Authors

1 Department of Pediatrics, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

2 Clinical Research Development Unit, Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran

3 Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran

4 Institute of Neuropharmacology, Kerman Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran

5 Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran

Abstract

BACKGROUND: Cardiovascular involvement represents a potentially serious complication associated with novel coronavirus disease 2019 (COVID-19), particularly among pediatric patients. Data regarding echocardiographic findings remain sparse, especially in low- and middle-income countries. The primary objective of this study was to investigate the echocardiographic findings of hospitalized children with COVID-19 in southeast Iran.
METHODS: This was a cross-sectional study of hospitalized pediatric COVID-19 patients in Kerman, southeast Iran, between March 2020 and March 2022. Clinical records of patients who had undergone transthoracic echocardiograms were evaluated. Demographic and clinical data, as well as echocardiographic findings—including left ventricular (LV) dysfunction, coronary involvement, valvular abnormalities, and pericardial effusion—were noted. Serum inflammatory markers were also assessed.
RESULTS: Data from a total of 188 children were analyzed. The mean age (± standard deviation) was 52.7 ± 4.9 months, and 61.4% were male. In terms of disease severity, 36.1% were categorized as moderate, 47.9% as severe, and 16.0% as multisystem inflammatory syndrome in children (MIS-C). Overall, 92.0% had abnormal echocardiographic findings—most commonly pericardial effusion (55.9%), valvular dysfunction (44.1%), coronary artery involvement (36.7%), and LV dysfunction (19.1%). Mitral regurgitation (36.2%) and tricuspid regurgitation (19.7%) were the most common valvular involvements. Moreover, coronary ectasia (19.7%) and dilatation (13.3%) were the prominent coronary abnormalities. LV dysfunction and valvular abnormalities were associated with increased mechanical ventilation, ICU admission, and mortality. Elevated erythrocyte sedimentation rate (ESR) was associated with valvular dysfunction, while higher NT-proBNP was associated with LV dysfunction.
CONCLUSION: Hospitalized children had a high prevalence of echocardiographic abnormalities, with LV and valvular dysfunction correlating with worse prognosis and inflammation. Echocardiography appears valuable for risk stratification in ventilator support and Intensive Care Unit (ICU) admission in pediatric patients; however, further research is needed on long-term cardiac sequelae.

Keywords

1. El-Sadr WM, Vasan A, El-Mohandes A. Facing the New Covid-19 Reality. N Engl J Med. 2023 Feb 2;388(5):385-7. https://doi.org/10.1056/nejmp2213920
2. Abadi B, Ilaghi M, Shahsavani Y, Faramarzpour M, Oghazian MB, Rahimi HR. Antibiotics with Antiviral and Anti-Inflammatory Potential Against Covid-19: A Review. Curr Rev Clin Exp Pharmacol. 2023;18(1):51-63. https://doi.org/10.2174/2772432817666220106162013
3. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-42. https://doi.org/10.1001/jama.2020.2648
4. Ladhani SN, Amin-Chowdhury Z, Davies HG, Aiano F, Hayden I, Lacy J, et al. COVID-19 in children: analysis of the first pandemic peak in England. Arch Dis Child. 2020 Dec;105(12):1180-85. https://doi.org/10.1136/archdischild-2020-320042
5. Sinaei R, Pezeshki S, Parvaresh S, Sinaei R. Why COVID-19 is less frequent and severe in children: a narrative review. World J Pediatr. 2021 Feb;17(1):10-20. https://doi.org/10.1007/s12519-020-00392-y
6. Valverde I, Singh Y, Sanchez-de-Toledo J, Theocharis P, Chikermane A, Di Filippo S, et al. Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe. Circulation. 2021 Jan 5;143(1):21-32. https://doi.org/10.1161/circulationaha.120.050065
7. Sinaei R, Hosseininasab A, Jafari M, Eslami S, Parvaresh S. The Multisystem Inflammatory Syndrome of Childhood (MIS-C). Indian J Pediatr. 2021 May;88(5):484. https://doi.org/10.1007/s12098-020-03617-0
8. Sinaei R, Pezeshki S, Asadipour A, Shiari R, Sinaei R, Sinaei A. Anti-rheumatic drugs as potential anti-inflammatory, immunomodulatory agents against COVID-19: A systematic review. Pharm Sci 2021;27(Covid-19):S13–28. https://doi.org/10.34172/PS.2021.40
9. Perisetti A, Goyal H, Gajendran M, Boregowda U, Mann R, Sharma N. Prevalence, Mechanisms, and Implications of Gastrointestinal Symptoms in COVID-19. Front Med (Lausanne). 2020 Oct 30;7:588711. https://doi.org/10.3389/fmed.2020.588711
10. Andina-Martinez D, Nieto-Moro M, Alonso-Cadenas JA, Añon-Hidalgo J, Hernandez-Martin A, Perez-Suarez E, et al. Mucocutaneous manifestations in children hospitalized with COVID-19. J Am Acad Dermatol. 2021 Jul;85(1):88-94. https://doi.org/10.1016/j.jaad.2021.03.083
11. Nejad Biglari H, Sinaei R, Pezeshki S, Khajeh Hasani F. Acute transverse myelitis of childhood due to novel coronavirus disease 2019: The first pediatric case report and review of literature. Iran J Child Neurol. 2021 Winter;15(1):107-12. https://doi.org/10.22037/ijcn.v15i1.31579
12. Vasichkina E, Alekseeva D, Karev V, Podyacheva E, Kudryavtsev I, Glushkova A, et al. Cardiac Involvement in Children Affected by COVID-19: Clinical Features and Diagnosis. Diagnostics 2022;13(1):120. https://www.mdpi.com/2075-4418/13/1/120#
13. Ho JS, Sia CH, Chan MY, Lin W, Wong RC. Coronavirus-induced myocarditis: A meta-summary of cases. Heart Lung. 2020 Nov-Dec;49(6):681-5. https://doi.org/10.1016/j.hrtlng.2020.08.013
14. Rodriguez-Gonzalez M, Castellano-Martinez A, Cascales-Poyatos HM, Perez-Reviriego AA. Cardiovascular impact of COVID-19 with a focus on children: A systematic review. World J Clin Cases. 2020 Nov 6;8(21):5250-83. https://doi.org/10.12998/wjcc.v8.i21.5250
15. Szekely Y, Lichter Y, Taieb P, Banai A, Hochstadt A, Merdler I, et al. Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study. Circulation. 2020 Jul 28;142(4):342-53. https://doi.org/10.1161/circulationaha.120.047971
16. Karimi A, Ghafouri P, Alilou S, Rezaei N, Ashraf Talesh S, et al. Echocardiographic Findings in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Systematic Review.Inn J Pediatr.2022;32(2):e119001. https://doi.org/10.5812/ijp.119001
17. Rostami-Maskopaee F, Ladomenou F, Razavi-Amoli SK, Navaeifar MR, Hajialibeig A, Shahbaznejad L, et al. Clinical characteristics and outcomes of the multisystem inflammatory syndrome in children (MIS-C) following COVID-19 infection in Iran: A multicenter study. PLoS One. 2022 Sep 22;17(9):e0274104. https://doi.org/10.1371/journal.pone.0274104
18Centers for Disease Control and Prevention. Information for healthcare providers about Multisystem Inflammatory Syndrome in Children (MIS-C) [Internet]. 2020. Available from: https://www.cdc.gov/mis/mis-c/hcp_cstecdc/?utm_medium=email&utm_source=transaction
19Sokunbi O, Akinbolagbe Y, Akintan P, Oyeleke G, Kusimo O, Owowo U, et al. Clinical presentation and short-term outcomes of multisystemic inflammatory syndrome in children in Lagos, Nigeria during the COVID-19 pandemic: A case series. EClinicalMedicine. 2022 May 27;49:101475. https://doi.org/10.1016/j.eclinm.2022.101475
20. Sabri MR, Ahmadi A, Saviz M, Ghaderian M, Dehghan B, Mahdavi C, Ramezani Nezhad D, Rahimi H, Mostafavi N, Pourmoghaddas Z. Cardiac Function in Pediatric Patients with MIS-C Using Speckle Tracking and Conventional Echocardiography: A Longitudinal, Single-Center Study. Pediatr Cardiol. 2025 Feb;46(2):383-93. https://doi.org/10.1007/s00246-024-03432-w
21. Diniz MFR, Cardoso MF, Sawamura KSS, Menezes CRB, Lianza AC, Pereira MFB, et al. The Heart of Pediatric Patients with COVID-19: New Insights from a Systematic Echocardiographic Study in a Tertiary Hospital in Brazil. Arq Bras Cardiol. 2021 Nov;117(5):954-64. https://doi.org/10.36660/abc.20200920
22Williams V, Dash N, Suthar R, Mohandoss V, Jaiswal N, Kavitha TK, et al. Clinicolaboratory Profile, Treatment, Intensive Care Needs, and Outcome of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2: A Systematic Review and Meta-analysis. J Pediatr Intensive Care. 2020 Nov 19;11(1):1-12https://doi.org/10.1055/s-0040-1719173
23Rostad BS, Shah JH, Rostad CA, Jaggi P, Richer EJ, Linam LE, et al. Chest radiograph features of multisystem inflammatory syndrome in children (MIS-C) compared to pediatric COVID-19. Pediatr Radiol. 2021 Feb;51(2):231-8. https://doi.org/10.1007/s00247-020-04921-9
24Sharma C, Ganigara M, Galeotti C, Burns J, Berganza FM, Hayes DA, et al. Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison. Nat Rev Rheumatol. 2021 Dec;17(12):731-48. https://doi.org/10.1038/s41584-021-00709-9
25Wessels PA, Bingler MA. A comparison of Kawasaki Disease and multisystem inflammatory syndrome in children. Prog Pediatr Cardiol. 2022 Jun;65:101516. https://doi.org/10.1016/j.ppedcard.2022.101516
26Wu EY, Campbell MJ. Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19. Curr Cardiol Rep. 2021 Oct 1;23(11):168. https://doi.org/10.1007/s11886-021-01602-3
27Alkan G, Sert A, Oz SKT, Emiroglu M, Yılmaz R. Clinical features and outcome of MIS-C patients: an experience from Central Anatolia. Clin Rheumatol. 2021 Oct;40(10):4179-89. https://doi.org/10.1007/s10067-021-05754-z
28Acevedo L, Piñeres-Olave BE, Niño-Serna LF, Vega LM, Gomez IJA, Chacón S, et al. Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study). BMC Pediatr. 2021 Nov 18;21(1):516. https://doi.org/10.1186/s12887-021-02974-9
29Kozlov IA, Sokolov DA. Assessment of the Myocardial Stress Biomarker NT-proBNP in Real Clinical Practice. Gen Reanimatol: 4.
30Kavurt AV, Bağrul D, Gül AEK, Özdemiroğlu N, Ece İ, Çetin İİ, et al. Echocardiographic Findings and Correlation with Laboratory Values in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19. Pediatr Cardiol. 2022 Feb;43(2):413-25. https://doi.org/10.1007/s00246-021-02738-3
31Stasiak A, Perdas E, Smolewska E. Risk factors of a severe course of pediatric multi-system inflammatory syndrome temporally associated with COVID-19. Eur J Pediatr. 2022 Oct;181(10):3733-8. https://doi.org/10.1007/s00431-022-04584-8
32Rahimzadeh G, Ekrami Noghabi M, Kadkhodaei Elyaderani F, Navaeifar MR, Enayati AA, Manafi Anari A, et al. COVID-19 Infection in Iranian Children: A Case Series of 9 Patients. J Pediatr Rev. 2020;8(2):139–44. http://dx.doi.org/10.32598/jpr.8.2.139
33Gul M, Ozyilmaz S, Bastug Gul Z, Kacmaz C, Satilmisoglu MH. Evaluation of cardiac injury with biomarkers and echocardiography after COVID-19 infection. J Physiol Pharmacol. 2022 Feb;73(1). https://doi.org/10.26402/jpp.2022.1.09